3 Ways Valeant Turned Allergan Misfire Into Salix Victory
Valeant Pharmaceuticals International Inc. threw down the hammer Monday when it increased its offer to acquire Salix Pharmaceuticals Ltd. to about $15.8 billion including debt, causing Endo Pharmaceuticals Inc. to drop out of...To view the full article, register now.
Already a subscriber? Click here to view full article